Research output per year
Research output per year
Fingerprint
Dive into the research topics where Minetta C Liu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
-
CANCER AND ACUTE LEUKEMIA GROUP B (CALGB) INST GRANT
Liu, M. C., Kinney, L., Kinney, L. & Kinney, L.
Project: Research project
Research output
-
A clinical calculator to predict disease outcomes in women with triple-negative breast cancer
Polley, M. Y. C., Leon-Ferre, R. A., Leung, S., Cheng, A., Gao, D., Sinnwell, J., Liu, H., Hillman, D. W., Eyman-Casey, A., Gilbert, J. A., Negron, V., Boughey, J. C., Liu, M. C., Ingle, J. N., Kalari, K., Couch, F., Carter, J. M., Visscher, D. W., Nielsen, T. O. & Goetz, M. P., Feb 2021, In: Breast Cancer Research and Treatment. 185, 3, p. 557-566 10 p.Research output: Contribution to journal › Review article › peer-review
-
Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance
Jalalirad, M., Haddad, T. C., Salisbury, J. L., Radisky, D., Zhang, M., Schroeder, M., Tuma, A., Leof, E., Carter, J. M., Degnim, A. C., Boughey, J. C., Sarkaria, J., Yu, J., Wang, L., Liu, M. C., Zammataro, L., Malatino, L., Galanis, E., Ingle, J. N., Goetz, M. P. & 1 others, , Apr 8 2021, In: Oncogene. 40, 14, p. 2509-2523 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Categorisation of patients based on immune profiles: a new approach to identifying candidates for response to checkpoint inhibitors
Bornschlegl, S., Gustafson, M. P., Delivanis, D. A., Ryder, M., Liu, M. C., Vasmatzis, G., Hallemeier, C. L., Park, S. S., Roberts, L. R., Parney, I. F., Jelinek, D. F. & Dietz, A. B., 2021, In: Clinical and Translational Immunology. 10, 4, e1267.Research output: Contribution to journal › Article › peer-review
Open Access -
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial)
Ruddy, K. J., Zheng, Y., Tayob, N., Hu, J., Dang, C. T., Yardley, D. A., Isakoff, S. J., Valero, V. V., Faggen, M. G., Mulvey, T. M., Bose, R., Sella, T., Weckstein, D. J., Wolff, A. C., Reeder-Hayes, K. E., Rugo, H. S., Ramaswamy, B., Zuckerman, D. S., Hart, L. L., Gadi, V. K. & 25 others, , 2021, (Accepted/In press) In: Breast Cancer Research and Treatment.Research output: Contribution to journal › Article › peer-review
-
Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients
Paoletti, C., Regan, M. M., Niman, S. M., Dolce, E. M., Darga, E. P., Liu, M. C., Marcom, P. K., Hart, L. L., Smith, J. W., Tedesco, K. L., Amir, E., Krop, I. E., DeMichele, A. M., Goodwin, P. J., Block, M., Aung, K., Brown, M. E., McCormack, R. T. & Hayes, D. F., Dec 2021, In: npj Breast Cancer. 7, 1, 77.Research output: Contribution to journal › Article › peer-review
Open Access